JIR
ICUI icon

James Investment Research’s ICU Medical ICUI Stock Holding History

James Investment Research’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,830
Closed -$2.21M – 846
2018
Q3 		$2.21M Buy
+7,830
New +$2.29M 0.09% 263

Other funds holding ICUI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

James Investment Research's ICUI Position: Q4 2018 in Review

James Investment Research sold out of ICU Medical (ICUI) in Q4 2018, closing a stake of 7,830 shares — an estimated $2.21M sold.

James Investment Research first reported a position in ICUI in Q3 2018 and held it in 1 quarter. The position peaked at $2.21M in Q3 2018. 294 funds tracked by Wall St. Rank hold ICUI as of Q4 2018.

  • James Investment Research reported no remaining ICU Medical position as of Q4 2018 after selling out during the quarter.
  • James Investment Research sold 7,830 ICU Medical shares in Q4 2018, an estimated $2.21M.
  • James Investment Research first reported a position in ICU Medical in Q3 2018 and held it in 1 quarter.
  • James Investment Research's ICU Medical position peaked at $2.21M in Q3 2018.
  • 294 funds tracked by Wall St. Rank held ICU Medical as of Q4 2018.

Based on James Investment Research's 13F filing for Q4 2018, filed 22 Jan 2019.